Cladribine is a medication used to treat hairy cell leukemia. However, the drug can contain certain impurities that may affect its safety and efficacy. Cladribine impurities may include related substances, degradation products, or residual solvents. It is important to monitor and control these impurities to ensure the quality and safety of the drug for patients.